Long before Dean F. Bajorin, MD, would travel the world as a renowned expert in genitourinary cancerspresenting at international conferences, working with major task forces, and changing the paradigms of care for patients in every corner of the globehe began with a decidedly shorter journey: to college.
The College of the Holy Cross in Worcester, Massachusetts, was a good school, but Bajorin chose it not so much for its academic reputation as its proximity. It allowed him to be a day student and save money by living at home.
Bajorin enrolled in the premed program, but becoming a doctor was not top of mind. He saw himself as a scientist and majored in physics with a minor in math. He also spent a good deal of time working with what was then a novel technology: computers. Back in the 70s, that was really unheard of, he said. In fact, we used punch cards to do linear accelerator experiments in physics.In retrospect, that early background as a scientist tackling new technology seems a fitting prelude to his future career.
When I wanted to get into medical school, people looked at me and said, You know, they dont need people who are mathematical and do computer programs, Bajorin recalled.
Bajorin subsequently graduated from New York Medical College, followed by a residency at Hartford Hospital in Connecticut. His initial interest was in cardiology, so he was happy to be at a hospital that had a major interventional cardiology program. His future, though, turned on a broken arm. He was performing an OB/GYN rotation, but he couldnt work in the delivery room with his injury.
The head of his program scrambled to find a spot for him. The only [opening] at the time was in oncology, and so he said, Sorry, thats where youre going, recalled Bajorin
That apology turned out to be unnecessary. Bajorin loved the rotation so much that he eventually altered his plans and the course of his career.
When he considers why he made the switch from cardiology to oncology, Bajorin explained that it had to do with the relationships he was able to build with patients as an oncologist.
Cardiologists, of course, have relationships with patients, but Bajorin said the immediacy and emotional impact of a cancer diagnosis changed the quality of his doctor-patient relationships.With cancer, everything is on the line, and its immediately on the line, he said. It was like ICU care, but in the outpatient setting. Everything was magnified.
While a fellow, he and colleagues also sought to figure out why there was such variation in terms of survival among patients with testis cancer. One group of patients was likely to survive, so minimizing toxicity was key. Other patients were at high risk for death and required very intensive therapy.
Distinguishing between the 2 groups, therefore, became critically important. Unfortunately, the 4 major staging systems used to make treatment decisions were woefully flawed.
I took the same group of patients and I applied each [system]and I showed how dramatically different they were, he said. So the results that those investigators were publishing were not because of their chemotherapy, but because they selected different populations of patients.
It was a transformational moment, Bajorin said. Now, instead of risk stratification purely based on anatomical sites of disease, were including biomarkers, and it has made a difference for all men with testis cancer in the world.
Bajorin said the new criteria helped physicians better tailor treatment and minimize toxicities for patients with testis cancer, allowing low-risk patients to choose less intensive treatment.
Bajorin has spent his career pushing forward the field of genitourinary cancer by developing new treatments, forging new paradigms in multimodal therapy, and searching for biomarkers and their clinical implications. He led phase 2 trials of chemotherapy drugs including docetaxel, pemetrexed, and the combination therapy of gemcitabine, carboplatin, and bevacizumab (Avastin).
Bajorin was convinced he could improve upon predictive factors beyond just staging systems to construct a better way to assess potential therapies. This work led to a breakthrough in 1999: Karnofsky performance status and visceral metastasis could be predictive of patient survival times. Those risk factors became known as the Bajorin criteria and emerged as a tool for patient stratification in clinical trials for bladder cancer.
In 2016, he and colleagues published widely cited research assessing atezolizumab (Tecentriq). That work helped lead to the accelerated approval of the drug in 2017 for patients with locally advanced or metastatic urothelial carcinoma who were ineligible for cisplatin-based therapy. The following year, he coauthored the results of the KEYNOTE-045 study, which found that pembrolizumab (Keytruda) was superior to chemotherapy as a second-line therapy for patients with advanced urothelial carcinoma.
The FDA later limited both agents to use in patients who are not eligible for cisplatin-containing therapy and whose tumors express PD-L1 or who are not eligible for any platinum-containing chemotherapy regardless of PD-L1 status. They also are approved in progressive disease settings.
In addition to seeing himself as a scientist, and then as a clinician, Bajorin said one other role is central to the way he thinks about his contributions to the field of oncology: teacher.
Thats been my major emphasis in terms of my careertraining the next generation of physicians, medical oncologists, physician-scientists, and clinical scientists, he said.
In fact, Bajorin has taught at MSK since graduating from medical school in 1986. He has also led the centers fellowship in medical oncology/hematology since 1994, making him the longest-tenured oncology fellowship director in the United States. When he first started, he said he worked to develop new standards and new opportunities for translational scientists who could provide top-tier clinical care while also performing research at the highest level. We needed to create that infrastructure and support mechanisms for that, he said.
Read the rest here:
Making an Impact in the Fight Against GU Cancers as Scientist, Physician, and Teacher - OncLive
- Interventional Cardiology Fellowship - Massachusetts General Hospital ... - April 8th, 2018 [April 8th, 2018]
- Dr. Eric Lo - Daytona Beach FL, Interventional Cardiology - April 18th, 2018 [April 18th, 2018]
- Interventional Cardiology | Cardiology Associates of East ... - April 19th, 2018 [April 19th, 2018]
- ECU Interventional Cardiology Fellowship - May 26th, 2018 [May 26th, 2018]
- Interventional Cardiology | Knoxville Heart Group - June 6th, 2018 [June 6th, 2018]
- Interventional Cardiology Fellowship - Massachusetts ... - June 14th, 2018 [June 14th, 2018]
- Scottsdale Interventional Forum | Cardiology Conference ... - June 21st, 2018 [June 21st, 2018]
- Interventional Cardiology - Terumo Europe - August 12th, 2018 [August 12th, 2018]
- Interventional Cardiology Fellowship | Cardiovascular Fellowship - September 20th, 2018 [September 20th, 2018]
- Interventional > Cardiovascular Medicine | Internal Medicine ... - September 20th, 2018 [September 20th, 2018]
- Interventional Cardiology Journal | Peer reviewed Journal - September 24th, 2018 [September 24th, 2018]
- Interventional Cardiology | North Florida Regional Medical ... - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology | Department of Medicine ... - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology | Medical City Fort Worth - October 4th, 2018 [October 4th, 2018]
- Cardiology and Interventional Cardiology | Texas Tech ... - October 4th, 2018 [October 4th, 2018]
- Invasive & Interventional Cardiology Section | Cleveland Clinic - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology - Crozer-Keystone Health System - PA - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology - Florida Medical Clinic - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology | Heart Hospital of New Mexico - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology | ColumbiaDoctors - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiologist Jobs | Glassdoor - October 4th, 2018 [October 4th, 2018]
- What are Invasive, Non-Invasive, and Interventional Cardiology? - October 4th, 2018 [October 4th, 2018]
- Interventional Cardiology Fellowship | Internal Medicine - October 25th, 2018 [October 25th, 2018]
- Interventional Cardiology | Community Health Network - October 25th, 2018 [October 25th, 2018]
- Interventional Cardiology | Ohio State Medical Center - October 25th, 2018 [October 25th, 2018]
- Interventional Cardiology | Stanford Health Care - October 25th, 2018 [October 25th, 2018]
- Interventional Cardiology - Montefiore Medical Center - November 10th, 2018 [November 10th, 2018]
- Interventional Cardiologists near Brooklyn, NY - Healthgrades - November 10th, 2018 [November 10th, 2018]
- Cardiac Catheterization | Interventional Cardiology in New ... - November 20th, 2018 [November 20th, 2018]
- What are Invasive, Non-Invasive, and Interventional ... - November 27th, 2018 [November 27th, 2018]
- Dr. Jaffar A Raza - Secaucus NJ, Interventional Cardiology - November 30th, 2018 [November 30th, 2018]
- Interventional cardiology - Wikipedia - December 13th, 2018 [December 13th, 2018]
- Interventional Cardiology | St. Francis - December 21st, 2018 [December 21st, 2018]
- Interventional Cardiologists near Secaucus, NJ - Healthgrades - December 21st, 2018 [December 21st, 2018]
- Interventional Cardiology Conferences & Meetings - December 25th, 2018 [December 25th, 2018]
- Interventional Cardiology - Baylor Heart and Vascular Hospital - January 18th, 2019 [January 18th, 2019]
- Interventional Cardiology - nationwidechildrens.org - January 18th, 2019 [January 18th, 2019]
- General & Interventional Cardiology - WakeMed - January 18th, 2019 [January 18th, 2019]
- Interventional Cardiology - University of Mississippi Medical ... - January 18th, 2019 [January 18th, 2019]
- Interventional Cardiologists in Austin, TX | Austin Heart - February 22nd, 2019 [February 22nd, 2019]
- Interventional Cardiology | Sutter Health - February 22nd, 2019 [February 22nd, 2019]
- Interventional Cardiology - St. Mary's Hospital and Health ... - February 22nd, 2019 [February 22nd, 2019]
- London & Milan - Cardiology Fellowships - February 22nd, 2019 [February 22nd, 2019]
- Interventional Cardiology | Saint Luke's Health System - February 22nd, 2019 [February 22nd, 2019]
- Interventional Cardiology | American Medical Association - February 22nd, 2019 [February 22nd, 2019]
- Interventional Cardiology | Piedmont Heart Institute ... - March 12th, 2019 [March 12th, 2019]
- Interventional Cardiology | UCSF Cardiology - March 18th, 2019 [March 18th, 2019]
- If You Are Referred to an Interventional Cardiologist - April 1st, 2019 [April 1st, 2019]
- Cardiology and Interventional Medicine | Veterinary ... - April 5th, 2019 [April 5th, 2019]
- Interventional Cardiology | AdventHealth Cardiovascular ... - May 11th, 2019 [May 11th, 2019]
- APSIC - Asian Pacific Society of Interventional Cardiology - May 13th, 2019 [May 13th, 2019]
- Interventional Cardiology | UNC REX Healthcare | Raleigh ... - May 20th, 2019 [May 20th, 2019]
- Interventional Cardiology - montefiore.org - May 20th, 2019 [May 20th, 2019]
- Women and heart health: Heart attack signs and symptoms to know about - The Indian Express - September 26th, 2019 [September 26th, 2019]
- Tiara for Treatment of Mitral Regurgitation and Neovasc Reducer for Treatment of Refractory Angina to be Featured at TCT 2019 Conference - Canada... - September 26th, 2019 [September 26th, 2019]
- TherOx to Present on SuperSaturated Oxygen (SSO2) at TCT2019 Next Week - BioSpace - September 26th, 2019 [September 26th, 2019]
- Too tired? it can indicate heart failure - The New Indian Express - September 26th, 2019 [September 26th, 2019]
- Blue Sail Medical and Biosensors International enter the Structural Heart market with the acquisition of Switzerland based NVT AG. content= - PR... - September 26th, 2019 [September 26th, 2019]
- Global Diagnostic Interventional Cardiology Instruments Market forecast by 2025 : Numerous tactics accepted by industry participants in a bid to... - September 26th, 2019 [September 26th, 2019]
- UMA's Complete Conference Management Hosts "Full Spectrum of Heart Failure Therapy: Optimizing Outcomes" - Yahoo Finance - September 26th, 2019 [September 26th, 2019]
- Meet the best cardiologists at King's Interactive Heart Health Morning - Gulf News - September 26th, 2019 [September 26th, 2019]
- Lights, camera, action in Varnville - Bluffton Today - September 26th, 2019 [September 26th, 2019]
- Health Pro: Cardiologist takes pleasure in getting patients back on their feet - Florida Today - September 26th, 2019 [September 26th, 2019]
- From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection - TCTMD - September 26th, 2019 [September 26th, 2019]
- Robocath Successfully Carries Out Its First Robotic Coronary Angioplasties in Humans - TCTMD - September 26th, 2019 [September 26th, 2019]
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ABIOMED, Inc. of Class Action Lawsuit and Upcoming... - September 28th, 2019 [September 28th, 2019]
- Study links childhood obesity with screen time - The Hindu - September 28th, 2019 [September 28th, 2019]
- Tiara for Treatment of Mitral Regurgitation and Neovasc Reducer for Treatment of Refractory Angina to be Featured at TCT 2019 Conference - BioSpace - September 28th, 2019 [September 28th, 2019]
- Five Atlantic Health System Team Members Lauded by NJ American Heart Association for Life-Saving Measures - TAPinto.net - September 28th, 2019 [September 28th, 2019]
- World Heart Day 2019: Cardiovascular Disease Is The World's Biggest Killer And Claims More Than 17.5 Million Lives - Outlook India - September 28th, 2019 [September 28th, 2019]
- Consulting Cardiologists Brings Exceptional Care to Heart of WH - Patch.com - September 28th, 2019 [September 28th, 2019]
- Diagnostic Interventional Cardiology Devices Market 2019| Global Forecast to 2026 with Key Players- B. Braun Medical, Boston Scientific, Cook Medical,... - September 28th, 2019 [September 28th, 2019]
- Surmodics Inc. (SRDX) and Its Competitors Comparing side by side. - MS Wkly - October 17th, 2019 [October 17th, 2019]
- Global Price, Sales and Revenue Analysis of Diagnostic Interventional Cardiology Devices Market by Regions, Manufacturers, Types and Applications -... - October 17th, 2019 [October 17th, 2019]
- Global Interventional Cardiology Devices Market Study by Price, Type and Application, Statistical Forecast and Competitive Landscape Research upto... - October 17th, 2019 [October 17th, 2019]
- Global Interventional Cardiology Market Report, Trends, CAGR Standing, Analysis and Forecasts (2019-2025) | Key Companies BIOTRONIK SE & Co.... - October 17th, 2019 [October 17th, 2019]
- Interventional Cardiology Market 2019 to Flourish with an Impressive CAGR of XX% in the year 2024, Predicts Market Research Future According to... - October 17th, 2019 [October 17th, 2019]
- FDA Approves Coronary ViperWire Advance With Flex Tip - Diagnostic and Interventional Cardiology - October 23rd, 2019 [October 23rd, 2019]
- Teleflex Announces Third Quarter 2019 Earnings Conference Call Information Live Webcast is scheduled at 8:00 am (ET) on Thursday, October 31, 2019 -... - October 23rd, 2019 [October 23rd, 2019]
- Global Interventional Cardiology Devices Market Analysis and CAGR during the Forecasting years of 2019-2025. - Air News Paper - October 23rd, 2019 [October 23rd, 2019]